Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24526N0332
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp has been awarded a $17,351.60 delivery order by Veterans Integrated Service Network 5 (VISN 5) for Tyvaso 64 microgram inhalation kits, with an ultimate completion date of February 25, 2026. This firm fixed-price award, issued without a set-aside designation, is being fulfilled at a facility in Bartlett, Tennessee. The delivery order falls under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) and represents a continuation of United Therapeutics' established role as a primary supplier of specialized pulmonary arterial hypertension treatments to the Department of Veterans Affairs.
This award is executed under a larger $207.1 million single-award Blanket Purchase Agreement between United Therapeutics Corp and the VA National Acquisition Center, valued through April 23, 2026. The BPA encompasses four critical pharmaceutical products—Unituxin, Remodulin, Tyvaso, and Orenitram—enabling the VA's Veterans Health Administration to efficiently procure these specialized medications at pre-negotiated prices across multiple regional networks nationwide. As a self-certified small disadvantaged business, United Therapeutics has become instrumental to the VA's mission of ensuring reliable access to essential treatments for veterans with life-threatening medical conditions.
Quick answers
Who was awarded contract 36C24526N0332?
36C24526N0332 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 18, 2026.
How much is contract 36C24526N0332 worth?
The government has obligated $17,352 on 36C24526N0332.
Is contract 36C24526N0332 an order under another contract?
Yes. 36C24526N0332 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0332 competed?
The extent of competition for 36C24526N0332 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award